What does PHARMASOLUTIONS do?

PHARMASOLUTIONS is a pharmacy in Linkebeek. Private Limited, started on 3 January 2023, 1 establishment.

What is the address of PHARMASOLUTIONS?

The registered office of PHARMASOLUTIONS is located at Grasmusdreef 44, 1630 Linkebeek.

Is PHARMASOLUTIONS still active?

Yes. According to the CBE (30 October 2026) PHARMASOLUTIONS is active, legal situation “Normale toestand”, started on 3 January 2023.

Is PHARMASOLUTIONS registered on Peppol?

Yes, PHARMASOLUTIONS is registered on the Peppol network with ID 0208:0795672093.

What is the enterprise number of PHARMASOLUTIONS?

The enterprise number of PHARMASOLUTIONS is BE0795672093.

When was PHARMASOLUTIONS founded?

PHARMASOLUTIONS was founded on 3 January 2023.

Who are the directors of PHARMASOLUTIONS?

According to the 2025 annual accounts, the directors of PHARMASOLUTIONS are: Niels Vrijens.

Is PHARMASOLUTIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 January 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMASOLUTIONS make in 2025?

PHARMASOLUTIONS posted a profit after taxes of € 70,854 in financial year 2025.

What is the revenue of PHARMASOLUTIONS?

As a small company, PHARMASOLUTIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 98,035.

PHARMASOLUTIONS (Private Limited) - Linkebeek

Dossier PHARMASOLUTIONS, printed on 30 October 2026 from databakkes.be/en/0795672093/pharmasolutions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMASOLUTIONS from Linkebeek, company number BE0795672093, closed financial year 2025 with a result of € 70,854 after tax. For that financial year PHARMASOLUTIONS recorded a gross margin of € 98,035 and equity of € 181,088. Compared with financial year 2024, the result moved from € 59,373 to € 70,854. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 181,088

▲ 64% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 70,854

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 192,680

▲ 99% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 180,088.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 298

▲ € 270 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,902

▲ 244% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 62,396 Gross margin 2023: € 62,396 First fiscal year in the series	€ 74,464 Gross margin 2024: € 74,464 ▲ 19% vs 2023 (€ 62,396) Favourable step	€ 98,035 Gross margin 2025: € 98,035 ▲ 32% vs 2024 (€ 74,464) Favourable step	▲ 32%
Profit after taxes	€ 49,861 Profit after taxes 2023: € 49,861 First fiscal year in the series	€ 59,373 Profit after taxes 2024: € 59,373 ▲ 19% vs 2023 (€ 49,861) Favourable step	€ 70,854 Profit after taxes 2025: € 70,854 ▲ 19% vs 2024 (€ 59,373) Favourable step	▲ 19%
Equity	€ 50,861 Equity 2023: € 50,861 First fiscal year in the series	€ 110,234 Equity 2024: € 110,234 ▲ 117% vs 2023 (€ 50,861) Favourable step	€ 181,088 Equity 2025: € 181,088 ▲ 64% vs 2024 (€ 110,234) Favourable step	▲ 64%
Total debts	€ 8,387 Total debts 2023: € 8,387 First fiscal year in the series	€ 10,259 Total debts 2024: € 10,259 ▲ 22% vs 2023 (€ 8,387) Unfavourable step	€ 34,348 Total debts 2025: € 34,348 ▲ 235% vs 2024 (€ 10,259) Unfavourable step	▲ 235%
Cash	€ 45,254 Cash 2023: € 45,254 First fiscal year in the series	€ 97,041 Cash 2024: € 97,041 ▲ 114% vs 2023 (€ 45,254) Favourable step	€ 192,680 Cash 2025: € 192,680 ▲ 99% vs 2024 (€ 97,041) Favourable step	▲ 99%
Retained profit	€ 49,861 Retained profit 2023: € 49,861 First fiscal year in the series	€ 109,234 Retained profit 2024: € 109,234 ▲ 119% vs 2023 (€ 49,861) Favourable step	€ 180,088 Retained profit 2025: € 180,088 ▲ 65% vs 2024 (€ 109,234) Favourable step	▲ 65%
Balance sheet total	€ 59,249 Balance sheet total 2023: € 59,249 First fiscal year in the series	€ 120,494 Balance sheet total 2024: € 120,494 ▲ 103% vs 2023 (€ 59,249) Unchanged	€ 215,437 Balance sheet total 2025: € 215,437 ▲ 79% vs 2024 (€ 120,494) Unchanged	▲ 79%

Key figures of PHARMASOLUTIONS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMASOLUTIONS?

What happened at PHARMASOLUTIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: profit of € 70,854 (▲ 19% vs 2024). Source: NBB ↗
Jan 3, 2023 New establishment in Linkebeek. KBO
2023 Niels Vrijens became a director. NBB
Jan 3, 2023 Start of the company according to the CBE. KBO

In short

From € 49,861 profit in 2023 to € 70,854 profit in 2025.

Paid € 54,549 in corporate taxes since 2023.

Best year ever: 2025, with € 70,854 profit.

Original PDFs at the National Bank ↗

Management

Niels Vrijens

PHARMASOLUTIONS

SEBASTIAAN

Behind PHARMASOLUTIONS is Niels Vrijens. Niels Vrijens is also behind SEBASTIAAN.

Directors

According to the 2025 annual accounts

Niels Vrijens

Director

Also active at: SEBASTIAAN

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Grasmusdreef 44

1630 Linkebeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0795.672.093
VAT number: BE 0795.672.093
Registered office: Grasmusdreef 44, 1630 Linkebeek
Names & denominations: PHARMASOLUTIONS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 January 2023
Peppol: Active · Active since 27 Oct 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗